Published in Bioorg Med Chem Lett on July 15, 2008
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity. J Biomed Sci (2010) 0.87
Poly[[bis-{μ(3)-2-[(3,5-dimethyl-1H-pyrazol-1-yl)(phen-yl)meth-yl]propane-dioato}tetra-sodium(I)] 7.5-hydrate]. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
Diethyl 2-{(dibenzyl-amino)[4-(trifluoro-meth-yl)phen-yl]meth-yl}malonate. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
Diethyl 2-[(3,5-dimethyl-1H-pyrazol-1-yl)(4-meth-oxy-phen-yl)meth-yl]propane-dioate. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
Diethyl 2-[(N-benzyl-N-methyl-amino)(phen-yl)meth-yl]propane-dioate. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
Diethyl 2-[phen-yl(pyrazol-1-yl)meth-yl]propane-dioate. Acta Crystallogr Sect E Struct Rep Online (2010) 0.75
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology (2005) 2.03
A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection. AIDS (2007) 1.71
Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc Natl Acad Sci U S A (2011) 1.61
Genome of the Chinese tree shrew. Nat Commun (2013) 1.55
An HIV-1 resistance polymorphism in TRIM5α gene among Chinese intravenous drug users. J Acquir Immune Defic Syndr (2011) 1.47
Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism. Adv Drug Deliv Rev (2009) 1.45
Biological evaluation of paclitaxel-peptide conjugates as a model for MMP2-targeted drug delivery. Cancer Biol Ther (2010) 1.45
Anti human immunodeficiency virus-1 (HIV-1) agents 1. Discovery of benzyl phenyl ethers as new HIV-1 inhibitors in vitro. Chem Pharm Bull (Tokyo) (2009) 1.39
Small molecule inhibitors of signal transducer and activator of transcription 3 (Stat3) protein. J Med Chem (2012) 1.39
Integrin targeted therapeutics. Theranostics (2011) 1.36
Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets (2007) 1.35
Synthesis and biological evaluation of dimeric RGD peptide-paclitaxel conjugate as a model for integrin-targeted drug delivery. J Med Chem (2005) 1.34
Small molecule inhibitors of CXCR4. Theranostics (2013) 1.30
Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology (2009) 1.29
18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy. J Nucl Med (2010) 1.28
Structural determinants for HIV-1 integrase inhibition by beta-diketo acids. J Biol Chem (2002) 1.26
Synthesis and antitumor activities of a series of novel quinoxalinhydrazides. Bioorg Med Chem (2006) 1.25
Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors. J Med Chem (2002) 1.25
Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment. Proc Natl Acad Sci U S A (2012) 1.18
Extensive and complex HIV-1 recombination between B', C and CRF01_AE among IDUs in south-east Asia. AIDS (2012) 1.17
Discovery of a small-molecule HIV-1 integrase inhibitor-binding site. Proc Natl Acad Sci U S A (2006) 1.16
Discovery of novel non-cytotoxic salicylhydrazide containing HIV-1 integrase inhibitors. Bioorg Med Chem Lett (2007) 1.16
Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors. Bioorg Med Chem (2006) 1.16
High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China. PLoS One (2012) 1.15
Design and synthesis of bis-amide and hydrazide-containing derivatives of malonic acid as potential HIV-1 integrase inhibitors. Molecules (2008) 1.13
Design, synthesis, molecular modeling, and anti-HIV-1 integrase activity of a series of photoactivatable diketo acid-containing inhibitors as affinity probes. Antiviral Res (2009) 1.12
Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase inhibitors. Bioorg Med Chem (2008) 1.12
Substituted 2-pyrrolinone inhibitors of HIV-1 integrase. Bioorg Med Chem Lett (2007) 1.11
Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. J Med Chem (2012) 1.10
Mining the NCI antiviral compounds for HIV-1 integrase inhibitors. Bioorg Med Chem (2006) 1.10
Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase. J Med Chem (2004) 1.10
Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP. Int J Cancer (2002) 1.09
Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents. J Med Chem (2006) 1.09
Synthesis and biological evaluation of N-acetyl-beta-aryl-1,2-didehydroethylamines as new HIV-1 RT inhibitors in vitro. Bioorg Med Chem Lett (2007) 1.07
The influence of age and sex on the cell counts of peripheral blood leukocyte subpopulations in Chinese rhesus macaques. Cell Mol Immunol (2009) 1.05
Comparison of HIV-, HBV-, HCV- and co-infection prevalence between Chinese and Burmese intravenous drug users of the China-Myanmar border region. PLoS One (2011) 1.05
Anti-infectives: clinical progress of HIV-1 integrase inhibitors. Expert Opin Emerg Drugs (2008) 1.04
Genotyping of TRIM5 locus in northern pig-tailed macaques (Macaca leonina), a primate species susceptible to Human Immunodeficiency Virus type 1 infection. Retrovirology (2009) 1.03
Adaptive evolution of primate TRIM5alpha, a gene restricting HIV-1 infection. Gene (2005) 1.02
Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore. Bioorg Med Chem (2007) 1.02
LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential. Eur J Pharmacol (2008) 1.02
Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors. Bioorg Med Chem (2008) 1.01
Inhibition of human immunodeficiency virus type 1 integration by diketo derivatives. Antimicrob Agents Chemother (2002) 1.01
Human immunodeficiency virus-1 genotypic drug resistance among volunteer blood donors in Yunnan, China. Transfusion (2009) 1.00
Photoaffinity labeling combined with mass spectrometric approaches as a tool for structural proteomics. Expert Rev Proteomics (2006) 1.00
Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J Med Chem (2011) 1.00
Pharmacophore guided discovery of small-molecule human apurinic/apyrimidinic endonuclease 1 inhibitors. J Med Chem (2009) 1.00
Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy. Trends Pharmacol Sci (2007) 1.00
Effect of HIV integrase inhibitors on the RAG1/2 recombinase. Proc Natl Acad Sci U S A (2001) 1.00
Allosteric inhibitor development targeting HIV-1 integrase. ChemMedChem (2011) 1.00
HIV-1 integrase inhibitors: 2005-2006 update. Med Res Rev (2008) 0.99
From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by beta-diketo acid metal complexes. J Med Chem (2006) 0.99
Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy. Clin Cancer Res (2004) 0.98
Discovery of novel small-molecule inhibitors of human epidermal growth factor receptor-2: combined ligand and target-based approach. J Med Chem (2008) 0.98
Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: effects of the phenyl substituent and the linker orientation. Bioorg Med Chem (2008) 0.98
Small-molecule inhibitors of p53-MDM2 interaction: the 2006-2010 update. Curr Pharm Des (2011) 0.98
Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer. Mol Cancer Ther (2013) 0.97
Synthesis and biological evaluation of novel dihydro-aryl/alkylsulfanyl-cyclohexylmethyl-oxopyrimidines (S-DACOs) as high active anti-HIV agents. Bioorg Med Chem Lett (2010) 0.97
New 23-spirocholestane derivatives from Ypsilandra thibetica. Planta Med (2013) 0.96
HIV integrase inhibitors with nucleobase scaffolds: discovery of a highly potent anti-HIV agent. J Med Chem (2006) 0.96
Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis. FEBS Lett (2008) 0.95
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity. PLoS One (2010) 0.94
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines. Mol Cancer Ther (2009) 0.94
VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription. Mol Cell (2013) 0.94
Molecular characterization of Trimeresurus stejnegeri venom L-amino acid oxidase with potential anti-HIV activity. Biochem Biophys Res Commun (2003) 0.94
Mapping the electron transfer interface between cytochrome b5 and cytochrome c. Biochemistry (2004) 0.94
Kuguacins F-S, cucurbitane triterpenoids from Momordica charantia. Phytochemistry (2008) 0.93
The anti-HIV-1 effect of scutellarin. Biochem Biophys Res Commun (2005) 0.93
Isatisine A, a novel alkaloid with an unprecedented skeleton from leaves of Isatis indigotica. Org Lett (2007) 0.93
Lycojapodine A, a novel alkaloid from Lycopodium japonicum. Org Lett (2009) 0.93
Synthesis and anti-HIV-1 activity of a novel series of 1,4,2-benzodithiazine-dioxides. Bioorg Med Chem Lett (2006) 0.92
Synthesis and anti-HIV-1 activities of novel podophyllotoxin derivatives. Bioorg Med Chem Lett (2006) 0.92
Stabilization of MDA-7/IL-24 for colon cancer therapy. Cancer Lett (2013) 0.91
Design of second generation HIV-1 integrase inhibitors. Curr Pharm Des (2007) 0.90
A new anti-HIV lupane acid from Gleditsia sinensis Lam. J Asian Nat Prod Res (2007) 0.90
Dendritic cell subsets dynamics and cytokine production in SIVmac239-infected Chinese rhesus macaques. Retrovirology (2010) 0.90
Four-tiered pi interaction at the dimeric interface of HIV-1 integrase critical for DNA integration and viral infectivity. Virology (2008) 0.90
Diketo acid pharmacophore. 2. Discovery of structurally diverse inhibitors of HIV-1 integrase. J Med Chem (2005) 0.90
Small-molecule HIV-1 integrase inhibitors: the 2001-2002 update. Curr Pharm Des (2003) 0.90
Molecular characterization, balancing selection, and genomic organization of the tree shrew (Tupaia belangeri) MHC class I gene. Gene (2013) 0.90
Phylodynamics of HIV-1 unique recombinant forms in China-Myanmar border: implication for HIV-1 transmission to Myanmar from Dehong, China. Infect Genet Evol (2012) 0.89
Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer. Eur J Nucl Med Mol Imaging (2008) 0.89
HIV-1 integrase inhibitors: an emerging clinical reality. Drugs R D (2007) 0.89
A nanoscale graphene oxide-peptide biosensor for real-time specific biomarker detection on the cell surface. Chem Commun (Camb) (2012) 0.89
Dynamic receptor-based pharmacophore model development and its application in designing novel HIV-1 integrase inhibitors. J Med Chem (2005) 0.89
Sifuvirtide, a potent HIV fusion inhibitor peptide. Biochem Biophys Res Commun (2009) 0.88
Lancifodilactone G: a unique nortriterpenoid isolated from Schisandra lancifolia and its anti-HIV activity. Org Lett (2005) 0.87
Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma. Jpn J Cancer Res (2002) 0.87